Language:

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

The New England journal of medicine, 2020-08, Vol.383 (6), p.517-525 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2016638 ;PMID: 32492293

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
Author: Boulware, David R ; Pullen, Matthew F ; Bangdiwala, Ananta S ; Pastick, Katelyn A ; Lofgren, Sarah M ; Okafor, Elizabeth C ; Skipper, Caleb P ; Nascene, Alanna A ; Nicol, Melanie R ; Abassi, Mahsa ; Engen, Nicole W ; Cheng, Matthew P ; LaBar, Derek ; Lother, Sylvain A ; MacKenzie, Lauren J ; Drobot, Glen ; Marten, Nicole ; Zarychanski, Ryan ; Kelly, Lauren E ; Schwartz, Ilan S ; McDonald, Emily G ; Rajasingham, Radha ; Lee, Todd C ; Hullsiek, Kathy H
Subjects: Adult ; Betacoronavirus ; Binding sites ; Canada ; Coronavirus Infections - prevention & control ; Coronaviruses ; COVID-19 ; COVID-19 diagnostic tests ; Disease transmission ; Double-Blind Method ; Drug dosages ; Enrollments ; FDA approval ; Female ; Humans ; Hydroxychloroquine ; Hydroxychloroquine - adverse effects ; Hydroxychloroquine - therapeutic use ; Infections ; Inhalation Exposure ; Internet ; Male ; Medical research ; Medicine, Experimental ; Middle Aged ; Occupational Exposure ; Original ; Pandemics - prevention & control ; Pharmacy ; Pneumonia, Viral - prevention & control ; Post-Exposure Prophylaxis ; Prophylaxis ; Quarantine ; Risk exposure ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Treatment Failure ; United States
Is Part Of: The New England journal of medicine, 2020-08, Vol.383 (6), p.517-525
Description: In this double-blind, randomized trial, 821 asymptomatic persons with a high-risk or moderate-risk exposure to SARS-CoV-2 were assigned to receive hydroxychloroquine or placebo within 4 days after the exposure. No benefit in preventing illness compatible with Covid-19 was found.
Publisher: United States: Massachusetts Medical Society
Language: English
Identifier: ISSN: 0028-4793
EISSN: 1533-4406
DOI: 10.1056/NEJMoa2016638
PMID: 32492293
Source: ProQuest One Psychology
MEDLINE
ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

Searching Remote Databases, Please Wait